Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year.
Incyte Out Licenses Lymphoma Drug To InnoCare In Greater China
Incyte Corporation (NASDAQ:INCY) and InnoCare have entered into a collaboration and license agreement to develop and commercial tafasitamab in Greater China. Under the…
SVB Leerink Maintains Outperform on Xencor, Lowers Price Target to $53
SVB Leerink analyst Jonathan Chang maintains Xencor (NASDAQ:XNCR) with a Outperform and lowers the price target from $57 to $53.
Xencor Q2 EPS $0.87 Up From $(0.61) YoY, Sales $67.45M Up From $13.09M YoY
Xencor (NASDAQ:XNCR) reported quarterly earnings of $0.87 per share. This is a 242.62 percent increase over losses of $(0.61) per share from the same period last year. The company reported $67.45 million in sales this
The Daily Biotech Pulse: Pfizer’s Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell
• Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.